Evaluation of four different equations for calculating LDL-C with eight different direct HDL-C assays

Clinica Chimica Acta

Volumn 423, Issue , 2013, Pages 135-140

  Oliveira, Marcelo Jose Andrade ^a   van Deventer, Hendrick E ^b   Bachmann, Lorin M ^c   Warnick, G Russell ^d   Nakajima, Katsuyuki ^e   Nakamura, Masakasu ^f   Sakurabayashi, Ikunosuke ^g   Kimberly, Mary M ^h   Shamburek, Robert D ^a   Korzun, William J ^c   Myers, Gary L ⁱ   Miller, W Greg ^c   Remaley, Alan T ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b LANCET LABORATORIES   (South Africa)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d Health Diagnostics Laboratory   (United States)

^e Nakajima Associate   (Japan)

^f OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^g JICHI MEDICAL UNIVERSITY   (Japan)

^h American Association for Clinical Chemistry ^*

ⁱ NONE   (United States)

Author keywords

Cardiovascular disease; Cholesterol; Friedewald equation; Low density lipoproteins

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANALYTIC METHOD; ANANDARAJA EQUATION; ARTICLE; ASSAY; CARDIOVASCULAR RISK; CHEN EQUATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; EVALUATION RESEARCH; FRIEDEWALD EQUATION; HUMAN; HYPERTRIGLYCERIDEMIA; INFORMATION PROCESSING; INTERMETHOD COMPARISON; LIPID ANALYSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; ULTRACENTRIFUGATION; VUJOVIC EQUATION;

ALGORITHMS; BIOLOGICAL ASSAY; BLOOD CHEMICAL ANALYSIS; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; HUMANS;

EID: 84878514240     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2013.04.009     Document Type: Article

References (21)

1. Quehenberger O., Dennis E.A. The human plasma lipidome. N Engl J Med 2011, 365:1812-1823.
2. Bachorik P.S., Ross J.W. National Cholesterol Education Program recommendations for measurement of low-density lipoprotein cholesterol: executive summary. The National Cholesterol Education Program Working Group on Lipoprotein Measurement. Clin Chem 1995, 41:1414-1420.
3. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 2011, 128(Suppl. 5):S213-S256.
4. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
5. Branchi A., Rovellini A., Torri A., Sommariva D. Accuracy of calculated serum low-density lipoprotein cholesterol for the assessment of coronary heart disease risk in NIDDM patients. Diabetes Care 1998, 21:1397-1402.
6. Contois J.H., Warnick G.R., Sniderman A.D. Reliability of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B measurement. J Clin Lipidol 2011, 5:264-272.
7. Dong J., Guo H., Yang R., et al. Serum LDL- and HDL-cholesterol determined by ultracentrifugation and HPLC. J Lipid Res 2011, 52:383-388.
8. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
9. Srisawasdi P., Chaloeysup S., Teerajetgul Y., et al. Estimation of plasma small dense LDL cholesterol from classic lipid measures. Am J Clin Pathol 2011, 136:20-29.
10. Miller W.G., Myers G.L., Sakurabayashi I., et al. Seven direct methods for measuring HDL and LDL cholesterol compared with ultracentrifugation reference measurement procedures. Clin Chem 2010, 56:977-986.
11. van Deventer H.E., Miller W.G., Myers G.L., et al. Non-HDL cholesterol shows improved accuracy for cardiovascular risk score classification compared to direct or calculated LDL cholesterol in a dyslipidemic population. Clin Chem 2011, 57:490-501.
12. Anandaraja S., Narang R., Godeswar R., Laksmy R., Talwar K.K. Low-density lipoprotein cholesterol estimation by a new formula in Indian population. Int J Cardiol 2005, 102:117-120.
13. Vujovic A., Kotur-Stevuljevic J., Spasic S., et al. Evaluation of different formulas for LDL-C calculation. Lipids Health Dis 2010, 9:27.
14. Chen Y., Zhang X., Pan B., et al. A modified formula for calculating low-density lipoprotein cholesterol values. Lipids Health Dis 2010, 9:52.
15. Grundy S.M., Cleeman J.I., Merz C.N., et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol 2004, 44:720-732.
16. Warnick G.R., Wood P.D. National Cholesterol Education Program recommendations for measurement of high-density lipoprotein cholesterol: executive summary. The National Cholesterol Education Program Working Group on Lipoprotein Measurement. Clin Chem 1995, 41:1427-1433.
17. Tremblay A.J., Morrissette H., Gagne J.M., Bergeron J., Gagne C., Couture P. Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population. Clin Biochem 2004, 37:785-790.
18. Agrawal M., Spencer H.J., Faas F.H. Method of LDL cholesterol measurement influences classification of LDL cholesterol treatment goals: clinical research study. J Investig Med 2010, 58:945-949.
19. Liu J., Sempos C., Donahue R.P., Dorn J., Trevisan M., Grundy S.M. Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes. Diabetes Care 2005, 28:1916-1921.
20. Liu J., Sempos C.T., Donahue R.P., Dorn J., Trevisan M., Grundy S.M. Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease. Am J Cardiol 2006, 98:1363-1368.
21. Wilson P.W., Zech L.A., Gregg R.E., et al. Estimation of VLDL cholesterol in hyperlipidemia. Clin Chim Acta 1985, 151:285-291.